Help Define the Social Dimension of Safe-and-Sustainable-by-Design in Pharma

About the PHASE5 project

The growing emphasis on sustainability in innovation highlights the need to integrate Safe-and-Sustainable-by-Design (SSbD) principles early in product development. This approach is essential to advancing the objectives of the EU Chemicals Strategy for Sustainability under the European Green Deal. PHASE5 aims to strengthen the implementation and assessment of SSbD – particularly its socio-economic dimension (Step 5) – within the context of advanced materials in the pharmaceutical industry. The project will develop actionable recommendations to enhance SSbD integration into innovation, especially social sustainability aspects.

Take part in our survey

We want to hear from you! Which social aspects do you believe are essential for making pharmaceutical products more socially responsible?

Take our 15-minute survey and help us identify what really matters when assessing the social sustainability of pharma products.

Your insights will directly support the development of a robust and inclusive sustainability framework within the SSbD approach.

Thank you for your time and contribution,
The PHASE5 Research Team

Contact person:
claudia.mair@uni-graz.at
University of Graz

Take survey